Cargando…
The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma
Stromal and immune cells are major components of tumor microenvironment (TME) and affect the growth and development of thyroid carcinoma (THCA). However, data on the exact mechanisms that define the relationship between the TME and THCA remain scant. We calculated stromal and immune cells scores and...
Autores principales: | Wu, Pu, Shi, Jinyuan, Sun, Wei, Zhang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810132/ https://www.ncbi.nlm.nih.gov/pubmed/34898340 http://dx.doi.org/10.1080/21655979.2021.2005745 |
Ejemplares similares
-
Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: A case report
por: Wu, Hao, et al.
Publicado: (2021) -
Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
por: Wu, Pu, et al.
Publicado: (2021) -
Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021) -
Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
por: Wu, Pu, et al.
Publicado: (2022) -
Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese
por: Shi, Dian-Chun, et al.
Publicado: (2022)